Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
Clinical trial NCT05118360 · WITHDRAWN
Trial details
- NCT number
- NCT05118360
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-11-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.